Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Weijian Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Huashan Hospital of Fudan University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Reperfusion Injury, Ferroptosis, Hydrogen, Mitochondria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Mitochondrial dysfunction and reactive oxygen species (ROS) overexpression are crucial factors inducing neuronal ferroptosis in cerebral ischemia/reperfusion injury (CIRI). Some therapeutics like RNAs and anti‐oxidation drugs have been developed to regulate the functions of mitochondria, but are hardly delivered into brain effectively due to the blood‐brain barrier (BBB). H 2 has recently been verified able to overcome the BBB efficiently and has a unique wide‐spectrum anti‐oxidation/anti‐inflammation effect, but sustainable, high‐amount, and safe delivery of H 2 into brain is still challenging currently. Herein, we develop an innovative H 2 administration method of intraperitoneal injection of magnesium hydride microparticles (MgH 2 ) with a high payload of hydrogen and a sustained hydrolytic H 2 production behavior, achieving persistent and high‐dose supply of H 2 into the blood system as well as in the brain. In addition, we establish a novel CIRI rabbit model induced by transcarotid artery revascularization (TCAR), which leads to oxidative stress and subsequent ferroptosis in the brain's hippocampus. In this CIRI model, MgH 2 treatment eliminates intracellular ROS, inhibits neuronal ferroptosis, and recovers mitochondrial dysfunction by stabilizing mitochondrial membrane potential, regulating mitobiogenesis, promoting neuronal energy metabolism, and activating the anti‐oxidative pathway. All these findings demonstrate that MgH 2 treatment provides a potential strategy for CIRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Huashan Hospital of Fudan University, Shanghai, P. R. China.
- Shanghai Key Laboratory of Hydrogen Science & Center of Hydrogen Science, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai, P. R. China.
- Department of Dermatology, Huashan Hospital of Fudan University, Shanghai, P. R. China.
ORCID-Profile: Weijian Fan, Jinyun Tan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Fan, W., Guan, Q., Xu, Z., Lin, L., Du, J., Yu, B., Ding, W., Yang, H., Pei, J., & Tan, J. (2026). Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502482
Vancouver
Fan W, Guan Q, Xu Z, Lin L, Du J, Yu B, et al. Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502482
BibTeX
@article{Fan2026,
author = {Fan, Weijian and Guan, Qingqing and Xu, Zhiheng and Lin, Lanmei and Du, Juan and Yu, Bo and Ding, Wenjiang and Yang, Haiyan and Pei, Jia and Tan, Jinyun},
title = {Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502482}
}
EUVIMED